Background: Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) with programmed cell death protein 1 (PD-1) inhibitors has been associated with risk of developing immune-mediated adverse reactions (IMARs). Objectives: This review provides nurses...

Background: Patients with head and neck cancer (HNC) face unique financial challenges. Even with stable income and health insurance, many patients become overwhelmed with direct and indirect treatment-associated costs. Objectives: This article discusses how prolonged financial burden in patients...

Background: Palliative care programs in the United States are becoming more integrated with oncology outpatient practices. Objectives: This article offers a condensed review of available literature on the usefulness of palliative care in the oncology clinic setting and a case study to illustrate...